Evidence
Molecules. 2023 Aug 4;28(15):5870. doi: 10.3390/molecules28155870.
ABSTRACT
Bile acids are acknowledged as signaling molecules involved in metabolic syndrome. The Takeda G protein-coupled receptor 5 (TGR5) functions as a significant bile acid receptor. The accumulated evidence suggests that TGR5 involves lipid homeostasis, glucose metabolism, and inflammation regulation. In line with this, recent preclinical studies also demonstrate that TGR5 plays a significant role in the generation and progression of metabolic syndrome, encompassing type 2 diabetes mellitus, obesity, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD). In this review, we discuss the role of TGR5 in metabolic syndrome, illustrating the underlying mechanisms and therapeutic targets.
PMID:37570840 | DOI:10.3390/molecules28155870
Add to Google Keep
Post to X
Share on Linkedin
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome
🌐 90 Days
VR Related Evidence Matrix
Evidence Blueprint
Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome
🌐 365 Days
VR Related Evidence Matrix
